# The Efficacy and Safety of Aracmyn in Patients With Systemic Latrodectism

> **NCT00247078** · PHASE2 · COMPLETED · sponsor: **Instituto Bioclon S.A. de C.V.** · enrollment: 24 (actual)

## Conditions studied

- Arachnidism
- Latrodectism

## Interventions

- **BIOLOGICAL:** widow spider antivenom
- **BIOLOGICAL:** Placebo

## Key facts

- **NCT ID:** NCT00247078
- **Lead sponsor:** Instituto Bioclon S.A. de C.V.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-10
- **Primary completion:** 2006-10
- **Final completion:** 2006-12
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2016-03-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00247078

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00247078, "The Efficacy and Safety of Aracmyn in Patients With Systemic Latrodectism". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00247078. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*